| New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy) acetamides against Mycobacterium tuberculosis BC Giacobbo, K Pissinate, V Rodrigues-Junior, AD Villela, ES Grams, ... European Journal of Medicinal Chemistry 126, 491-501, 2017 | 50 | 2017 |
| 1H-Benzo [d] imidazoles and 3, 4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity FS Macchi, K Pissinate, AD Villela, BL Abbadi, V Rodrigues-Junior, ... European Journal of Medicinal Chemistry 155, 153-164, 2018 | 29 | 2018 |
| Activity of 2-(quinolin-4-yloxy) acetamides in Mycobacterium tuberculosis clinical isolates and identification of their molecular target by whole-genome sequencing FT Subtil, AD Villela, BL Abbadi, VS Rodrigues-Junior, CV Bizarro, ... International Journal of Antimicrobial Agents 51 (3), 378-384, 2018 | 28 | 2018 |
| Revisiting activation of and mechanism of resistance to compound IQG-607 in Mycobacterium tuberculosis BL Abbadi, AD Villela, VS Rodrigues-Junior, FT Subtil, PF Dalberto, ... Antimicrobial Agents and Chemotherapy 62 (2), 10.1128/aac. 02222-17, 2018 | 14 | 2018 |
| Thermodynamics, functional and structural characterization of inosine–uridine nucleoside hydrolase from Leishmania braziliensis PF Dalberto, LKB Martinelli, JFR Bachega, LFSM Timmers, AFM Pinto, ... RSC advances 7 (77), 48861-48875, 2017 | 1 | 2017 |
| Identificação do alvo molecular das 2 (quinolin-4-ilóxi) acetamidas como candidatos a fármacos para o tratamento da tuberculose FT Subtil Pontifícia Universidade Católica do Rio Grande do Sul, 2017 | | 2017 |
| Identifica?? o do alvo molecular das 2 (quinolin-4-il? xi) acetamidas como candidatos af? rmacos para o tratamento da tuberculose FT Subtil | | 2017 |
